Author Details

Князев, Олег Владимирович

Issue	Section	Title	File
Vol 82, No 2 (2010)	Editorial article	USE of allogeneic mesenchymal stem cells in the treatment of intestinal inflammatory diseases
Vol 90, No 3 (2018)	Editorial article	Stem Cell Therapy for Perianal Crohn’s Disease	(Rus)
Vol 90, No 6 (2018)	Editorial article	Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practice	(Rus)
Vol 90, No 2 (2018)	Editorial article	Personalized medicine in the treatment of inflammatory bowel diseases	(Rus)
Vol 90, No 2 (2018)	Editorial article	Mesenchymal stromal cells of bone marrow and azathioprine in Crohn's disease therapy	(Rus)
Vol 90, No 12 (2018)	Editorial article	Adherence to therapy of patients with inflammatory bowel diseases	(Rus)
Vol 90, No 11 (2018)	Editorial article	Clostridium difficile in inflammatory bowel disease	(Rus)
Vol 91, No 2 (2019)	Editorial article	Important problems in the diagnosis and treatment of primary sclerosing cholangitis (based on the Russian consensus on diagnosis and treatment autoimmune hepatitis. Moscow, 2018)	(Rus)
Vol 90, No 12 (2018)	Editorial article	Biomarkers of inflammatory bowel disease activity	(Rus)
Vol 91, No 2 (2019)	Editorial article	Celiac disease associated with ulcerative colitis	(Rus)
Vol 91, No 4 (2019)	Editorial article	O.V. Knyazev, A.V. Kagramanova, I.A. Korneeva, K.K. Noskova, S.V. Belousov, A.I. Parfenov	(Rus)
Vol 91, No 8 (2019)	Editorial article	Evaluation of efficacy and comparative frequency of adverse events in patients with ulcerative colitis receiving the original infliximab and its biosimilar. One year of observation	(Rus)
Vol 92, No 2 (2020)	Editorial article	Systemic manifestations of inflammatory bowel diseases	(Rus)
Vol 92, No 2 (2020)	Original articles	Pharmacological and clinical feature of rebamipide: new therapeutic targets	(Rus)
Vol 93, No 2 (2021)	Original articles	Loss of response and frequency of adverse events in patients with ulcerative colitis and Crohn’s disease when switching from the original infliximab to its biosimilars	(Rus)
Vol 93, No 8 (2021)	Reviews	Is histological remission of ulcerative colitis achievable?	(Rus)
Vol 93, No 12 (2021)	Editorial article	Low adherence to treatment is a weak link in the problems of ulcerative colitis	(Rus)
Vol 93, No 12 (2021)	Original articles	Histological remission of ulcerative colitis with combined anti-cytokine and cell therapy	(Rus)
Vol 93, No 12 (2021)	History of medicine	Ulcerative colitis. To the 180th anniversary of the description by Karl Rokytansky	(Rus)
Vol 94, No 2 (2022)	Original articles	Frequency and risk factors for thromboembolic complications in patients with inflammatory bowel diseases	(Rus)
Vol 95, No 2 (2023)	History of medicine	Crohn disease: before and after 1932 year	(Rus)
Vol 95, No 11 (2023)	Case reports	Tuberculosis infection in patients with inflammatory bowel diseases. Clinacal cases	(Rus)
Vol 96, No 2 (2024)	Case reports	Ulcerative colitis and autoimmune uveitis. Case report	(Rus)
Vol 97, No 2 (2025): Вопросы гастроэнтерологии	Original articles	Prevention of venous thromboembolic complications in patients with ulcerative colitis	(Rus)
Vol 97, No 2 (2025): Вопросы гастроэнтерологии	Original articles	Results of non-medical switching from original infliximab to its Russian biosimilar in patients with ulcerative colitis	(Rus)
Vol 97, No 2 (2025): Вопросы гастроэнтерологии	Consensuns	Russian Cross-disciplinary Consensus on the diagnosis and treatment of spondyloarthritis associated with inflammatory bowel diseases	(Rus)
Vol 97, No 2 (2025): Вопросы гастроэнтерологии	History of medicine	Evolution of enterology as a science	(Rus)

Username
Password
Remember me

Forgot password?	Register

Username
Password
Remember me

Forgot password?	Register